COMMUNIQUÉS West-GlobeNewswire

Total Ancillary Launches Healthview360™

16/01/2025 - 15:57

Wound Care Management SaaS Platform is First of its Kind DALLAS, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Wound care management innovator Total Ancillary announces the full market launch of Healthview360™, an advanced SaaS ( [...]

Lung Health Foundation Announces New Leaders to Reshape Lung Healthcare in Canada

16/01/2025 - 16:00

TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The Lung Health Foundation (LHF) is poised to reshape the future of lung healthcare in Canada with the appointment of three dynamic leaders to tackle an escalating public [...]

Boehringer provides update on iclepertin Phase III program in schizophrenia

16/01/2025 - 16:05

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were not met. 1–6 [...]

USOSM Enters 2025 Strong, Announces New Partner Practice in South Carolina

16/01/2025 - 17:05

IRVING, Texas, Jan. 16, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM) – a management services company that exclusively serves premier oral and maxillofacial surgeons – has formed a new partnership with [...]

VIRBAC: Forte progression du chiffre d'affaires : +13.6% sur l'année, soutenue par une croissance organique dynamique (+7.5%) et l'apport stratégique de nos acquisitions (+6.1%)

16/01/2025 - 17:45

Forte progression du chiffre d'affaires : +13.6% sur l'année, soutenue par une croissance organique dynamique (+7.5%) et l'apport stratégique de nos acquisitions (+6.1%) Communiqué diffusé le 16 janvier 2025 après [...]

Virbac: Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)

16/01/2025 - 17:45

Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%) Press release issued on January 16, 2025 after market close at 5:45pm CET KEY [...]

Vaxil Bio Proposed Reverse Takeover With Green Date Terminated

16/01/2025 - 20:35

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States NESS-ZIONA, Israel, Jan. 16, [...]

Aledade Launches Policy Institute to Shape Value-Based Care Transformation

16/01/2025 - 21:30

Policy Institute to convene national experts and inform policies that strengthen primary care and drive value-based care adoption nationwide BETHESDA, Md., Jan. 16, 2025 (GLOBE NEWSWIRE) -- To strengthen primary care [...]

Scilex Holding Company Amends its License Agreement with Romeg Therapeutics, LLC, For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adults

16/01/2025 - 21:38

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. Over 70% of gout patients have comorbid conditions that may [...]

Scorpius Holdings Announces Reverse Stock Split

16/01/2025 - 22:05

DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced [...]

Codexis Appoints Christos Richards to Board of Directors

16/01/2025 - 22:05

REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of [...]

ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses

16/01/2025 - 22:05

PORTLAND, Maine, Jan. 16, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]

Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs

14/01/2025 - 14:00

COVID-19 Phase 2b study poised to initiate 10,000 participant portion of trial pending U.S. Food and Drug Administration (FDA) review of sentinel cohort 30-day safety data Norovirus program to proceed with Phase 1 study [...]

Adagene to Host Virtual KOL Event to Discuss Anti-CTLA-4 SAFEbody® ADG126 in Advanced/Metastatic Microsatellite-Stable (MSS) Colorectal Cancer (CRC) on January 25, 2025

14/01/2025 - 14:00

SAN DIEGO and SUZHOU, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced it will [...]

Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss

14/01/2025 - 14:00

OGM uniquely identified a complex chromosomal rearrangement missed by classical cytogenetics, helping clinical researchers apply targeted screening to select the most fit embryos for transfer Following in-vitro [...]

E8, Inc. Announces Collaborative Partnership with Jacobs Institute to Make Minimally Invasive Solutions the Gold Standard in Neurosurgery

14/01/2025 - 14:00

Minimally Invasive Surgical Access Systems Require Dedicated Instruments to Transform Neurosurgery LOS GATOS, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- E8, Inc. unveiled its next-generation suite of tools designed to [...]

Annovis Granted U.S. Patent for Treatment and Prevention of Acute Brain or Nerve Injuries Securing Global Protection

14/01/2025 - 14:00

MALVERN, Pa, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]

Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio

14/01/2025 - 14:00

First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in H2 2025 Phase 2 trial of VTX2735 in participants with recurrent [...]

Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus’s Spinoff Company for Rose Bengal-Based Eye Drugs

14/01/2025 - 14:00

KNOXVILLE, Tenn., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced a $3 million seed financing round for VisiRose, Inc. (“VisiRose”), [...]